2010 perinatal GBS prevention guideline and resource utilization

Area of Science:

• Neonatal Medicine
• Infectious Disease Prevention
• Public Health Guidelines

Background:

• Early-onset sepsis (EOS) evaluations are critical for neonatal health.
• Adherence to Centers for Disease Control and Prevention (CDC) guidelines is essential for preventing perinatal infections.
• Previous guidelines (2002) may have led to over-evaluation of infants.

Purpose of the Study:

• To compare early-onset sepsis (EOS) evaluations before and after adopting the CDC 2010 guidelines.
• To quantify changes in resource utilization and costs associated with EOS evaluations.
• To assess the impact on EOS detection rates.

Main Methods:

• Retrospective cohort study of infants born at ≥36 weeks' gestation (2009-2012).
• Comparison of two 12-month periods: one using CDC 2002 guideline, the other using CDC 2010 guideline.
• Cost minimization analysis for EOS evaluation-associated expenses.

Main Results:

• EOS evaluations for inadequate Group B Streptococcus (GBS) prophylaxis decreased significantly (<1/1000 live births).
• EOS evaluation costs reduced by $6994 per 1000 live births.
• No increase in EOS evaluations for other reasons, NICU admissions, or EOS incidence was observed.

Conclusions:

• The CDC 2010 guideline-based EOS algorithm reduced evaluations by 25% in well-appearing infants.
• The reduction was primarily due to fewer evaluations for inadequate GBS prophylaxis.
• Significant savings in resource expenditures were achieved without compromising patient safety.